✦ LIBER ✦

Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease

✍ Scribed by Jae K. Ryu; Seung U. Kim; James G. McLarnon

Book ID: 116458195
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 936 KB
Volume: 187
Category: Article
ISSN: 0014-4886
DOI: 10.1016/j.expneurol.2004.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atypical diabetes associated with inclus

Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington’s disease is not improved by treatment with hypoglycaemic agents

✍ Mark J. Hunt; A. Jennifer Morton 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 420 KB

Deficits induced by quinolinic acid lesi

Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: A potential novel treatment in a rat model of Huntington's disease

✍ Daphna Joel; Liat Ayalon; Ricardo Tarrasch; Ina Weiner 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

## Abstract Symptoms in the early stages of Huntington's disease (HD) are assumed to reflect basal ganglia circuit dysfunction secondary to degeneration of striatal projections to the external segment of the globus pallidus (GPe). The hypothesis that GPe lesion would ameliorate HD symptoms by “norm

Early intervention with a single dose of

Early intervention with a single dose of doxorubicin followed by zoledronic acid induces sustained inhibition of breast cancer-induced bone disease in a mouse model

✍ H.K. Brown; P.D. Ottewell; C.A. Evans; R.E. Coleman; I. Holen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB